# Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing

> **NIH NIH N01** · INTERNATIONAL AIDS VACCINE INITIATIVE · 2024 · $2,131,382

## Abstract

The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of services spanning product development planning and feasibility assessments; product optimization; product development and cGMP compliant manufacture for Phase I/II clinical studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA). These services will facilitate the development and introduction of new vaccines and biologics. This contract also provides for manufacture of vaccines, vaccine components including adjuvants, vaccine delivery systems, other biologics, and challenge material.

## Key facts

- **NIH application ID:** 11042053
- **Project number:** 272201800010I-P00001-759302300001-1
- **Recipient organization:** INTERNATIONAL AIDS VACCINE INITIATIVE
- **Principal Investigator:** SANGEETHA SAGAR
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,131,382
- **Award type:** —
- **Project period:** 2023-09-26 → 2028-09-25

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11042053

## Citation

> US National Institutes of Health, RePORTER application 11042053, Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing (272201800010I-P00001-759302300001-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11042053. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*